Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III trial investigates TQB-2450 with anlotinib for advanced biliary cancer

April 6, 2021

Tsukushi protein mutations can lead to hydrocephalus

April 1, 2021

FDA approves Roszet to treat elevated LDL-C in primary nonfamilial hyperlipidemia and HoFH

April 1, 2021

Celon reports phase I data on second-generation GPR40 agonist CPL-280

April 1, 2021

U.S. approval for Sarclisa with Kd for relapsed or refractory multiple myeloma

April 1, 2021

Yingli reports phase II topline data on linperlisib in relapsed or refractory follicular lymphoma

April 1, 2021

China's NMPA approves Ayvakit for GIST with PDGFRA exon 18 mutation

April 1, 2021

Qinlock approved in China for advanced GIST

April 1, 2021

Primary safety endpoint met in phase Ib/II study of BXCL-501 to treat opioid withdrawal symptoms

April 1, 2021

COMMD1 as therapeutic target and diagnostic biomarker in NSCLC

April 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...